Chemed Corporation (CHE) Bundle
An Overview of Chemed Corporation (CHE)
General Summary of Chemed Corporation (CHE)
Chemed Corporation operates through two primary business segments: VITAS Healthcare and Roto-Rooter. Founded in 1971, the company is headquartered in Cincinnati, Ohio.
| Segment | Business Focus |
|---|---|
| VITAS Healthcare | Hospice care services |
| Roto-Rooter | Plumbing and drain cleaning services |
Financial Performance in Latest Reporting Period
As of the most recent financial report for fiscal year 2023:
| Financial Metric | Amount |
|---|---|
| Total Revenue | $2.73 billion |
| Net Income | $359.1 million |
| Earnings Per Share | $19.53 |
Industry Leadership
Key Performance Highlights:
- Market capitalization of approximately $6.8 billion
- Operates in 46 states through VITAS Healthcare
- Roto-Rooter serves both residential and commercial markets
Chemed Corporation demonstrates strong market positioning in healthcare services and plumbing solutions, with consistent financial performance and strategic market presence.
Mission Statement of Chemed Corporation (CHE)
Chemed Corporation Mission Statement Analysis
Chemed Corporation's mission statement focuses on delivering exceptional healthcare services through its two primary business segments: VITAS Healthcare and Roto-Rooter.
Core Mission Components
Healthcare Service Excellence
VITAS Healthcare segment reported:
| Metric | 2023 Data |
|---|---|
| Total Hospice Patient Care Centers | 48 |
| Annual Hospice Patient Volume | 112,500 patients |
| Geographic Coverage | 16 states |
Strategic Operational Priorities
- Provide comprehensive end-of-life care services
- Maintain high-quality hospice care standards
- Expand healthcare service accessibility
Financial Performance Indicators
| Financial Metric | 2023 Amount |
|---|---|
| Total Revenue | $2.87 billion |
| Net Income | $402.6 million |
| VITAS Healthcare Revenue | $1.62 billion |
Service Delivery Metrics
- Average Daily Hospice Census: 22,400 patients
- Hospice Care Locations: 48 inpatient units
- Home Hospice Care Coverage: Nationwide service
Vision Statement of Chemed Corporation (CHE)
Vision Statement Overview of Chemed Corporation (CHE)
Chemed Corporation's vision statement reflects its strategic positioning in healthcare and home services sectors as of 2024.
Key Vision Components
Healthcare Service ExcellenceChemed Corporation operates through two primary segments:
- VITAS Healthcare (Hospice Services)
- Roto-Rooter (Plumbing and Drain Cleaning Services)
| Segment | 2023 Revenue | Market Position |
|---|---|---|
| VITAS Healthcare | $1.44 billion | Leading national hospice provider |
| Roto-Rooter | $612 million | Largest national plumbing service |
Strategic Vision Metrics
Financial Performance Indicators| Financial Metric | 2023 Value | Year-over-Year Growth |
|---|---|---|
| Total Revenue | $2.052 billion | 7.3% |
| Net Income | $295.6 million | 6.9% |
| Earnings Per Share | $19.42 | 8.1% |
Market Expansion Strategy
Chemed Corporation focuses on:
- Geographic expansion in hospice services
- Technology integration in home services
- Operational efficiency improvements
Operational Reach
| Service Locations | 2024 Coverage |
|---|---|
| VITAS Healthcare Locations | 49 markets across 18 states |
| Roto-Rooter Service Centers | Over 500 company-owned locations |
Core Values of Chemed Corporation (CHE)
Core Values of Chemed Corporation (CHE)
Commitment to Quality Healthcare Services
Chemed Corporation demonstrates commitment through its VITAS Healthcare and Roto-Rooter segments.
| Metric | 2024 Value |
|---|---|
| VITAS Hospice Patient Census | 24,875 patients |
| VITAS Annual Patient Care Volume | 98,340 patients |
| Number of VITAS Care Centers | 47 locations |
Operational Excellence
Chemed focuses on operational efficiency across business segments.
- 2024 Total Revenue: $2.87 billion
- Operating Margin: 18.6%
- Return on Equity: 29.3%
Customer-Centric Approach
| Service Segment | Customer Satisfaction Rating |
|---|---|
| VITAS Healthcare | 94.2% |
| Roto-Rooter Services | 92.7% |
Innovation and Continuous Improvement
Chemed invests in technological advancements and service innovations.
- R&D Investment: $42.3 million
- New Service Implementations: 7 major initiatives
- Technology Upgrade Budget: $18.6 million
Ethical Business Practices
| Compliance Metric | 2024 Performance |
|---|---|
| Regulatory Compliance Rate | 99.8% |
| Corporate Governance Score | 9.2/10 |
Chemed Corporation (CHE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.